Patents by Inventor Giulio SANCINI

Giulio SANCINI has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Liposomes active in-vivo on neurodegenerative diseases
    Patent number: 10010505
    Abstract: New liposomes are described, comprising: (i) phosphatidic acid and/or cardiolipin; (ii) apolipoprotein E (ApoE) or derivatives thereof. The so modified liposomes, administered systemically, obtain a dramatic in-vivo reduction of the amyloid plaque in the central nervous system, allowing an effective treatment of neurodegenerative diseases, in particular Alzheimer's disease.
    Type: Grant
    Filed: October 2, 2014
    Date of Patent: July 3, 2018
    Assignee: UNIVERSITA DEGLI STUDI DI MILANO-BICOCCA
    Inventors: Massimo Masserini, Francesca Re, Giulio Sancini, Gianluigi Forloni, Mario Salmona
  • LIPOSOMES ACTIVE IN-VIVO ON NEURODEGENERATIVE DISEASES
    Publication number: 20150017235
    Abstract: New liposomes are described, comprising: (i) phosphatidic acid and/or cardiolipin; (ii) apolipoprotein E (ApoE) or derivatives thereof. The so modified liposomes, administered systemically, obtain a dramatic in-vivo reduction of the amyloid plaque in the central nervous system, allowing an effective treatment of neurodegenerative diseases, in particular Alzheimer's disease.
    Type: Application
    Filed: October 2, 2014
    Publication date: January 15, 2015
    Inventors: Massimo MASSERINI, Francesca RE, Giulio SANCINI, Gianluigi FORLONI, Mario SALMONA
  • Liposomes active in-vivo on neurodegenerative diseases
    Patent number: 8877236
    Abstract: New liposomes are described, comprising: (i) phosphatidic acid and/or cardiolipin; (ii) apolipoprotein E (ApoE) or derivatives thereof. The so modified liposomes, administered systemically, obtain a dramatic in-vivo reduction of the amyloid plaque in the central nervous system, allowing an effective treatment of neurodegenerative diseases, in particular Alzheimer's disease.
    Type: Grant
    Filed: June 28, 2012
    Date of Patent: November 4, 2014
    Assignee: Universita Degli Studi di Milano-Bicocca
    Inventors: Massimo Masserini, Francesca Re, Giulio Sancini, Gianluigi Forloni, Mario Salmona
  • LIPOSOMES ACTIVE IN-VIVO ON NEURODEGENERATIVE DISEASES
    Publication number: 20140004172
    Abstract: New liposomes are described, comprising: (i) phosphatidic acid and/or cardiolipin; (ii) apolipoprotein E (ApoE) or derivatives thereof. The so modified liposomes, administered systemically, obtain a dramatic in-vivo reduction of the amyloid plaque in the central nervous system, allowing an effective treatment of neurodegenerative diseases, in particular Alzheimer's disease.
    Type: Application
    Filed: June 28, 2012
    Publication date: January 2, 2014
    Inventors: Massimo MASSERINI, Francesca RE, Giulio SANCINI, Gianluigi FORLONI, Mario SALMONA